Jane Street’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $346K | Buy |
|
|||||
|
2024
Q4 | $205K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $191K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $151K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $752K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $748K | Buy |
|
|||||
|
2021
Q2 | $587K | Sell |
|
|||||
|
2021
Q1 | $895K | Buy |
|
|||||
|
2020
Q4 | $724K | Sell |
|
|||||
|
2020
Q3 | $945K | Sell |
|
|||||
|
2020
Q2 | $1.25M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $348K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $567K | Buy |
|
|||||
|
2018
Q3 | $203K | Sell |
|
|||||
|
2018
Q2 | $529K | Sell |
|
|||||
|
2018
Q1 | $1.46M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.18M | Buy |
|
|||||
|
2017
Q2 | $595K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $888K | Buy |
|
|||||
|
2016
Q3 | $275K | Sell |
|
|||||
|
2016
Q2 | $593K | Buy |
|
|||||
|
2016
Q1 | $233K | Buy |
|